Inhibition of HGF/MET signaling decreases overall tumor burden and blocks malignant conversion in Tpl2-related skin cancer
Inhibition of HGF/MET signaling decreases overall tumor burden and blocks malignant conversion in <i>Tpl2</i>-related skin cancer, Published online: 10 January 2019; doi:10.1038/s41389-018-0109-8
Inhibition of HGF/MET signaling decreases overall tumor burden and blocks malignant conversion in Tpl2-related skin cancer
from A via a.sfakia on Inoreader https://go.nature.com/2SMBWkj
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,